分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

VMP1 inhibits the progression of breast cancer via regulating PI3K/AKT and MEK/ERK signaling pathway

Chen Shuzhao, Liang Yuanke, Chen Huan, Wu Chengyu, Wang Zhenhao, Yang Ruiqian, Fang Xinqiang, Ma Yanyang, Lin Haoyu, Wei Xiaolong

Journal:Cancer Cell International

IF:6

DOI:10.1186/s12935-025-04149-3

PMID:

Published:2026-01-02

research field:

Abstract

Background Vacuolar membrane protein 1 (VMP1) is an endoplasmic reticulum - resident and multi - spanning membrane protein involved in various human cancers. However, its biological functions and molecular mechanisms in breast cancer remain underexplored. Methods Gene expression profiling was used to determine VMP1 levels. Western blot, qRT - PCR, and single - cell analysis were employed to confirm the findings. Functional assays such as knockdown and overexpression experiments were carried out to assess the effects on cell proliferation, colony formation, and migration. In vivo tumor growth experiments were also conducted. Additionally, clinical analysis of 117 breast cancer patient samples was performed to study the correlation between VMP1 expression and molecular subtypes. Results VMP1 was significantly upregulated in MCF − 7 cells line. Knockdown of VMP1 enhanced cell proliferation, colony formation, and migration, while overexpression suppressed tumor cell malignancy and inhibited tumor growth in vivo. Mechanistically, VMP1 was found to regulate key oncogenic signaling pathways, including PI3K/AKT and MEK/ERK. Clinical analysis showed that VMP1 expression was correlated with molecular subtypes. Conclusions In conclusion, our findings suggest that VMP1 plays a crucial role in breast cancer progression, and modulation of its expression or activity may offer a therapeutic strategy.

本文使用的Yeasen产品

购物车
客服
转染试用